Info-Contra: Role of Parents Concerning Information of Adolescents About Contraception

Sponsor
Université de Reims Champagne-Ardenne (Other)
Overall Status
Recruiting
CT.gov ID
NCT05647603
Collaborator
(none)
1,500
1
5
302.4

Study Details

Study Description

Brief Summary

Adolescence is a period of intensive physical and psychological changes, with notably the start of sexuality. During this period of sexual discovery, a lack or a misuse of contraception may be responsible for unwanted pregnancy.

So, sexual education and information about contraception are crucial. Teenagers often consult Internet or discuss with friends to have information but they can be not true or precise. They can also consult health professionals, however shyness and fear can hold them back. Information about contraception may also be given by their parents. The physical closeness and the trust that adolescents have in their parents can promote dialogue.

Condition or Disease Intervention/Treatment Phase
  • Other: data collection

Detailed Description

the aim of the study is to describe information about contraception given by parents to adolescents

Study Design

Study Type:
Observational
Anticipated Enrollment :
1500 participants
Observational Model:
Case-Only
Time Perspective:
Cross-Sectional
Official Title:
Role of Parents Concerning Information of Adolescents About Contraception
Actual Study Start Date :
Nov 1, 2022
Anticipated Primary Completion Date :
Jan 1, 2023
Anticipated Study Completion Date :
Apr 1, 2023

Arms and Interventions

Arm Intervention/Treatment
group "Parents of adolescents"

Parents of adolescents aged 12 to 18

Other: data collection
Information about contraception

Outcome Measures

Primary Outcome Measures

  1. Definition of contraception [Day 0]

    Parents have explained or not that contraception is all methods aimed at reversibly preventing an unwanted pregnancy

  2. Contraception methods [Day 0]

    Parents have explained or not all contraception methods (condom for man, condom for woman, control pills, contraceptive implant, intra-uterine device, contraceptive patch, contraceptive ring, spermicide

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Parents (father or mother) of adolescents (boy or girl) aged 12 to 18

  • agreeing to participate to the study

Exclusion Criteria:

Contacts and Locations

Locations

Site City State Country Postal Code
1 Université de Reims Champagne Ardenne Reims France 51100

Sponsors and Collaborators

  • Université de Reims Champagne-Ardenne

Investigators

  • Principal Investigator: Lapree Lucie, Université de Reims Champagne-Ardenne

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Université de Reims Champagne-Ardenne
ClinicalTrials.gov Identifier:
NCT05647603
Other Study ID Numbers:
  • 2022_RIPH_014_Info-Contra
First Posted:
Dec 12, 2022
Last Update Posted:
Dec 16, 2022
Last Verified:
Dec 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Université de Reims Champagne-Ardenne

Study Results

No Results Posted as of Dec 16, 2022